Karen Hamme

Karen Hamme is the President of Alimar Consulting, Inc., where they provide consultancy in regulatory affairs and quality assurance for pharmaceutical and biotech companies. Since 1997, they have worked as a regulatory affairs consultant, specializing in CMC and clinical programs, and have also served as a Senior Regulatory Compliance Manager at Genentech since 2020. Prior experience includes regulatory roles at Roche and Syntex. Karen is currently pursuing an MBA in Marketing from Notre Dame de Namur University and holds a BS in Biochemistry from the University of California, Davis.